Our current findings revealed that PTTG1 overexpression may enhance the effectiveness of luteolin by regulating the molecules involved in cell proliferation and cell-cycle progression in human myeloid leukemia cells. The gene discussed is PTTG1; the disease is myeloid leukemia.